Infectious diseases in sports

Medicine and Science in Sports and Exercise

Volumn 32, Issue 7 SUPPL., 2000, Pages

  Beck, C Keith ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Skin infections; Sports infections; Sports medicine; Vaccinations

Indexed keywords

CEFALEXIN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DICLOXACILLIN; ERYTHROMYCIN; LEVOFLOXACIN; PSEUDOMONIC ACID; VACCINE;

BACTERIAL INFECTION; HUMAN; INFECTION RISK; MYCOSIS; REVIEW; RISK ASSESSMENT; SKIN INFECTION; SOFT TISSUE INFECTION; SPORTS MEDICINE; VACCINATION; VIRUS TRANSMISSION;

EID: 0033927428     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005768-200007001-00008     Document Type: Review

References (49)

1. ANDERSSON, J., and I. ERNBERG. Management of Epstein-Barr virus infections. Am. J. Med. 85(Suppl. 2a):107-115, 1988.
2. ATKINSON, W. L., S. C. HADLER, S. B. REDD, et al. Measles surveillance: United States 1991. MMWR 41:1-12, 1992.
3. BART, B. Skin problems in athletics. Minnesota Med. 66:239-241, 1983.
4. BRANDFORBRENNER, A., A. EPSTEIN, S. WU, and J. PHAIR. Corticosteroid therapy in Epstein-Barr virus infection. Arch. Intern. Med. 146:337-339, 1986.
5. BUCHWALD, D., J. L. SULLIVAN, and A. L. KOMAROFF. Frequency of "chronic active Epstein-Barr virus infection" in a general medical practice. JAMA 257:2303-2307, 1987.
6. CAILLEAUX, V., M-J. DUPONT, B. HONG, et al. Why did infection with Aeromonas hydrophila occur when water contains so many other microorganisms? Clin. Infect. Dis. 16:174, 1993.
7. CALABRESE, L. H., and A. LE PERRIERE. Human immunodeficiency virus infection, exercise, and athletics. Sports Med. 15:6-13, 1993.
8. CENTERS FOR DISEASE CONTROL. Outbreak of acute febrile illness among athletes participating in triathlons - Wisconsin and Illinois, 1998. MMWR 47:585-588, 1998.
9. CENTERS FOR DISEASE CONTROL AND PREVENTION. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 47(No. RR-8:9-14), 1998.
10. CENTERS FOR DISEASE CONTROL. Measles at an international gymnastics competition - Indiana. MMWR 41(07:109-111), 1992.
11. CENTERS FOR DISEASE CONTROL AND PREVENTION. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 48(No. RR-12:10-14), 1999.
12. CENTERS FOR DISEASE CONTROL AND PREVENTION. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 40(No. RR-13:8-15), 1991.
13. CENTERS FOR DISEASE CONTROL. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 45(No. RR-11:13-14), 1996.
14. CENTERS FOR DISEASE CONTROL. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 40(No. RR-10: 6-12), 1991.
15. DANIELS, W. L., D. S. SHARP, J. E. WRIGHT, et al. Effects of virus infection on physical performance in man. Mil. Med. 150:8-14, 1985.
16. EICHNER, E. R., and L. H. CALABRESE. Immunology and exercise: physiology, pathophysiology and implications for HIV infection. Med. Clin. North Am. 78:377-388, 1994.
17. FARIZO, KM, S. L. COCHI, E. R. ZELL, et al. Epidemiological features of pertussis in the United States, 1980-1989. Clin. Infect. Dis J. 14:708-719, 1992.
18. FARLEY, D. R., S. P. ZIETLOW, M. P. BANNON, and M. B. FARNELL. Spontaneous rupture of the spleen due to infectious mononucleosis. Mayo Clin. Proc. 67:846-853, 1992.
19. FARRAR, W. E. Leptospira species (Leptospirosis). In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 4th Ed., G. L. Mandell, J. E. Bennett, and R. Dolin (Eds.). New York: Churchill Livingstone, 1995, pp. 21-40.
20. FELLER, A., and T. P. FLANIGAN. HIV-infected competitive athletes: what are the risks? What precautions should be taken? J. Gen. Int. Med. 12:243-246, 1997.
21. FITZGERALD, L. Overtraining increases the susceptibility to infection. Int. J. Sports Med. 1:S5-S8, 1991.
22. FRIMAN, G. Effect of acute infectious disease on isometric muscle strength. Scand. J. Clin. Lab Invest. 37:303-308, 1977.
23. FRIMAN, G., J. E. WRIGHT, N. G. ILBACK, et al. Does fever or myalgia indicate reduced physical performance capacity in viral infections? Acta Med. Scand. 217:353-361, 1985.
24. GOODMAN, R. A., S. B. THACKER, S. L. SOLOMON, et al. Infectious diseases in competitive sports. JAMA 271:862-867, 1994.
25. GWALTNEY, J. M., JR. Epidemiology of the common cold. Ann. N.Y. Acad. Sci. 353:54-60, 1980.
26. HARRINGTON, D. Viral hepatitis and exercise. Med. Sci. Sports Exerc. 32:S422-S430, 2000.
27. HOLMES, G. P. Defining the chronic fatigue syndrome. Rev. Infect. Dis. 13:S53-S55, 1991.
28. HORWITZ, C. A., W. HENLE, G. HENLE, et al. Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis. J. Infect. Dis. 151:1150-1153, 1985.
29. JOHANSON, W. G., JR., A. K. PIERCE, and J. P. SANFORD. Pulmonary function in uncomplicated influenza. Am. Rev. Respir. Dis. 100: 141-146, 1969.
30. JOKIPII, L., and A. M. M. JOKIPII. Timing of symptoms and oocyst excretion in human cryptosporidiosis. N Engl. J. Med. 315:1643-1647, 1986.
31. LITTLE, J. W., W. J. HALL, R. G. DOUGLAS, JR., et al. Airway hyperactivity and peripheral airway dysfunction in influenza A infection. Am. Rev. Respir. Dis. 118:295-303, 1978.
32. LITTLE, J. W., W. J. HALL, R. G. DOUGLAS, et al. Amantadine effect on peripheral airways abnormalities in influenza. Ann. Intern Med. 85:177-182, 1976.
33. MCGOWAN, J. E., JR., P. J. CHESNEY, K. B. CROSSLEY, and F. M. LAFORCE. Guidelines for the use of systemic glucocorticosteroids in the management of selected infections. Working Group on Steroid Use, Antimicrobial Agents Committee, Infectious Diseases Society of America. J. Infect. Dis. 165:1-13, 1992.
34. MCKEAG, D. B., and J. KINDERKNECHT. A basketball player with infectious mononucleosis. In: Common Problems in Pediatric Sports Medicine, N. J. Smith (Ed.). Chicago: Year Book Medical Publishers, 1989, p. 191.
35. MILLER, G., E. GROGAN, D. ROWE, et al. Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection. J. Infect. Dis. 156:26-35, 1987.
36. MINK, C. M., J. D. CHERRY, P. CHRISTENSON, et al. A search for Bordetella pertussis infection in university students. Clin. Infect. Dis. 14:464-471, 1992.
37. MORSE, L. J., J. A. BRYAN, J. P. HURLEY, et al. The Holy Cross College football team hepatitis outbreak. JAMA 219:706-708, 1972.
38. NEMECHEK, P. K. Anabolic steroid users: another potential risk group for HIV infection. N. Engl. J. Med. 325:357, 1991.
39. PORTER, D. D., I. WIMBERLY, and M. BENYESH-MELNICK. Prevalence of antibodies to EB virus and other herpesviruses. JAMA 208: 1675-1679, 1969.
40. RABORN, G. W., W. T. MCGAW, M. GRACE, et al. Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study. J. Am. Dent. Assoc. 115:38-42, 1987.
41. RICE, T. D., A. K. DUGGAN, and C. DEANGELIS. Cost-effectiveness of erythromycin versus mupirocin for treatment of impetigo in children. Pediatrics 89:210-214, 1992.
42. SEVIER, T. L. Infectious disease in athletes. Med. Clin. North Am. 78:389-412, 1994.
43. SHARP, J. C. M. Viruses and the athlete. Br. J. Sports Med. 23:47-48, 1989.
44. SHARP, J. C. M. Infections in sport. Br. Med. J. 308:1702-1706, 1994.
45. SPRUANCE, S. L., J. C. B. STEWART, N. M. ROWE, et al. Treatment of recurrent herpes simplex labialis with oral acyclovir. J. Infect. Dis. 161:185-190, 1990.
46. STRINGER, W. W. Mechanisms of exercise limitation in HIV+ individuals. Med. Sci. Sports Exerc. 32:S412-S421, 2000.
47. WEINSTEIN, L., and J. LE FROCK. Does antimicrobial therapy of streptococcal pharyngitis or pyoderma alter the risk of glomerulonephritis? J. Infect. Dis. 124:229-231, 1971.
48. WHITLEY, R. J., and J. W. GNANN. Acyclovir: a decade later. N. Engl. J. Med. 327:782-789, 1992.
49. WOLFE, M. S. Giardiasis. Clin. Microbiol. Rev. 5:93-100, 1992.